Meet BioMind® at ECR 2021
Incorporated in 2017, BioMind® is a ISO13485 certified medical device company and has a global headcount of over 200 staff across 3 offices worldwide. We have received many international accolades and lead the WHO-ITU AI4H radiotherapy committee.
Our Artificial intelligence-assisted diagnostic products have become a demand in the clinical diagnosis and treatment, having been deployed in more than 150 hospitals. It is also an indispensable tool for promoting the development of teaching and scientific research fields.
BioMind® is an award-winning Artificial Intelligence (AI) company providing machine intelligence solutions to assist in diagnosis and treatment. As the world’s first company to obtain both European CE mark and Singapore HSA medical device certifications for Brain Diagnostic Support Solution, we pride ourselves in empowering physicians through deep leaning technology.
Our AI application assists physicians in detecting, localizing and diagnosing neurological disorders on medical imaging, covering a wide spectrum of brain conditions such as stroke, brain tumors and vascular conditions. In early 2020, BioMind® developed new solutions to detect and assist in diagnosing COVID-19 pneumonia on CT scans.
BioMind® has been featured in over 120 media globally and has been crowned the Gold winner of Singapore Techblazer Award 2019, top winner of 19th Asia Pacific ICT Alliance Award (ICT & Security), listed as Top 8 innovations in Arab Health 2020 and Top 10 AI Powered Healthcare Companies in APAC by CIO outlook 2019, nominated as semifinalist in EuroMinnies 2020 (“Best Radiology Softward” and “Best New Radiology Vendor”) and the winner of COVID-19 detection using AI aw world AI Conference (WAIC) 2020.